Nrf2在子宫内膜样腺癌组织中的表达及其意义

doi:10.3969/j.issn.1671-7171.2021.06.033

Abstract
Figure/Table
References
Related Citation (15)

Download: PDF (1667 KB) HTML (1 KB)
Export: BibTeX | EndNote (RIS)

Abstract 【Objective】To investigate the expression and significance of Nrf2 in endometrioid adenocarcinoma. 【Methods】From January 2012 to December 2015, 5 cases of normal endometrium, 12 cases of endometrial hyperplasia, 11 cases of endometrial atypical hyperplasia and 26 cases of endometrioid adenocarcinoma were collected in the Department of pathology of our hospital. The expression level of Nrf2 in each tissue was detected by immunohistochemical method, and its clinical significance was analyzed. 【Results】 The high expression rate of Nrf2 in endometrioid adenocarcinoma, endometrial hyperplasia, atypical hyperplasia and normal endometrium was 88.5% (23/26), 66.7% (8/12), 63.6% (7/11) and 40% (2/5), respectively. The high expression rate of Nrf2 in endometrioid adenocarcinoma was significantly higher than that in normal endometrium, and the difference was statistically significant(χ²=6.31,P<0.05); There was no significant difference in the high expression rate between the other groups (mean P>0.05). The high expression rate of Nrf2 was not related to the age, stage, grade, tumor thrombus in vessels and the depth of myometrial invasion (mean P>0.05), but related to lymph node metastasis (P<0.05). 【Conclusion】 Nrf2 is overexpressed in endometrioid adenocarcinoma, which may play a role in promoting the occurrence, development and metastasis of endometrioid adenocarcinoma.

Key words： Endometrial Neoplasms/PA Transcription Factors Prognosis Risk Factors

Received: 06 May 2020

PACS:

R737.33

	Service

	E-mail this article
	Add to my bookshelf
	Add to citation manager
	E-mail Alert
	RSS
	Articles by authors

Cite this article:

URL:

http://journal07.magtech.org.cn/yxlcyj/EN/10.3969/j.issn.1671-7171.2021.06.033 OR http://journal07.magtech.org.cn/yxlcyj/EN/Y2021/V38/I6/918

[1] 周佳钦,曹佳璐,单静,等.MMR蛋白在子宫内膜癌组织中的表达水平及其临床意义[J].医学临床研究,2020,37(10):1532-1535.
[2] 顾佩蓓,吴婷婷,杨婷,等.Keap1-Nrf2信号通路参与子宫内膜癌细胞增殖、转移、耐药机制的研究[J].现代生物医学进展,2019,19(1):6-12.
[3] CHEN N, YI X F, ABUSHAHIN N,et al.Nrf2 expression in endometrial serous carcinomas and its precancers[J].Int J Clin Exp Pathol,2011,4(1):85-96.
[4] 邵坤,朱芳恒.乳腺癌中miR-141表达与临床病理特征、Keap1/Nrf2通路及预后的关系[J].分子诊断与治疗杂志,2021, 13(1):72-75.
[5] JAHAN N, CHOWDHURY A, LI T, et al.Neferine improves oxidative stress and apoptosis in benign prostate hyperplasia via Nrf2-ARE pathway[J].Redox Report,2021,26(1):1-9.
[6] 王静,陈洁,胡春,等.PI3K/AKT通路通过Nrf2途径调控PD-L1在非小细胞肺癌中的表达[J].中国癌症杂志,2020,30(6):419-427.
[7] 周昌东,杨新平,田玉新等.UHRF1高表达对膀胱癌细胞Keap1/Nrf2通路的调控作用分析[J].实用癌症杂志,2020,35(1):9-12.
[8] 庄依泽,梁宇,殷红专,等.NRF2 /HO-1因子与结直肠肿瘤TNM分期的相关性研究[J].现代肿瘤医学,2015,23(16):2318-2322.
[9] 田文秀,王晶,徐丹,等.miR-141靶向调控Keap1-Nrf2/HO-1信号通路对卵巢癌发生发展的影响[J].临床和实验医学杂志,2020,19(11):1183-1188.
[10] 段俊伟,倪文.Nrf2/PI3K通路介导肝癌细胞SMMC-7721出现索拉非尼耐药的机制研究[J].肝脏,2020,25(9):930-932.
[11] 张钧,孔德友,张舰,等.RNA干扰Nrf2表达对食管癌生物学行为的影响[J].临床肿瘤学杂志,2014,19(12):1057-1060.
[12] 顾玉彬.肾癌组织中转录因子E2相关因子2和胰岛素样生长因子-1的表达[J].肿瘤基础与临床,2016,29(3):198-200.
[13] 耿文静,单立兵,王金生,等.红系衍生的核因子2相关因子2在结节性甲状腺肿和甲状腺乳头状癌的表达及意义[J].中华肿瘤杂志, 2017, 39(5):367-368.